Cargando…
Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase
OBJECTIVE: To observe the influence of Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin (HCG) carrying heparanase (Hpa) antisense oligodeoxynucleotide (ASODN), via the invasion, proliferation, and Hpa expression of JEG-3 cell lines and inhibitory effect of transplanted choriocarcinoma tumor gro...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826771/ https://www.ncbi.nlm.nih.gov/pubmed/24235832 http://dx.doi.org/10.2147/IJN.S44739 |
_version_ | 1782290959533342720 |
---|---|
author | Huining, Liu Yi, Zhang Dihong, Tang Yifeng, Pan Man, Xia Ting, Yang Jingting, Cai |
author_facet | Huining, Liu Yi, Zhang Dihong, Tang Yifeng, Pan Man, Xia Ting, Yang Jingting, Cai |
author_sort | Huining, Liu |
collection | PubMed |
description | OBJECTIVE: To observe the influence of Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin (HCG) carrying heparanase (Hpa) antisense oligodeoxynucleotide (ASODN), via the invasion, proliferation, and Hpa expression of JEG-3 cell lines and inhibitory effect of transplanted choriocarcinoma tumor growth. METHODS: The different abilities of invasion and proliferation between transfected JEG-3 and untransfected JEG-3 were measured by Matrigel invasion assay and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay in vitro. The effect of Hpa ASODN transfection on the expression of Hpa mRNA and protein was measured by reverse-transcription polymerase chain reaction and Western blot. The transplanted choriocarcinoma tumors were taken out to calculate the inhibitory effect on tumor growth of Hpa ASODN. RESULTS: In this study, we found that: (1) the invasive ability of JEG-3 cells was inhibited sufficiently (P < 0.05) after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN; (2) after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN at 48 and 72 hours, the proliferative ability of JEG-3 cells was inhibited sufficiently (P < 0.05); (3) the expression of Hpa mRNA and protein in JEG-3 cells was inhibited efficiently after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN (P < 0.05); and (4) Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN had an inhibitory effect on the transplanted choriocarcinoma tumor growth (P < 0.05) and was harmless on nude mice. CONCLUSION: Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN weakened the invasive and proliferative ability of choriocarcinoma, with a significant inhibitory effect on the transplanted choriocarcinoma tumor. Therefore, Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN is an effective gene therapy, and Fe(3)O(4)-dextran-anti-βHCG nanoparticles are a harmless and effective gene vector. |
format | Online Article Text |
id | pubmed-3826771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-38267712013-11-14 Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase Huining, Liu Yi, Zhang Dihong, Tang Yifeng, Pan Man, Xia Ting, Yang Jingting, Cai Int J Nanomedicine Original Research OBJECTIVE: To observe the influence of Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin (HCG) carrying heparanase (Hpa) antisense oligodeoxynucleotide (ASODN), via the invasion, proliferation, and Hpa expression of JEG-3 cell lines and inhibitory effect of transplanted choriocarcinoma tumor growth. METHODS: The different abilities of invasion and proliferation between transfected JEG-3 and untransfected JEG-3 were measured by Matrigel invasion assay and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay in vitro. The effect of Hpa ASODN transfection on the expression of Hpa mRNA and protein was measured by reverse-transcription polymerase chain reaction and Western blot. The transplanted choriocarcinoma tumors were taken out to calculate the inhibitory effect on tumor growth of Hpa ASODN. RESULTS: In this study, we found that: (1) the invasive ability of JEG-3 cells was inhibited sufficiently (P < 0.05) after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN; (2) after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN at 48 and 72 hours, the proliferative ability of JEG-3 cells was inhibited sufficiently (P < 0.05); (3) the expression of Hpa mRNA and protein in JEG-3 cells was inhibited efficiently after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN (P < 0.05); and (4) Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN had an inhibitory effect on the transplanted choriocarcinoma tumor growth (P < 0.05) and was harmless on nude mice. CONCLUSION: Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN weakened the invasive and proliferative ability of choriocarcinoma, with a significant inhibitory effect on the transplanted choriocarcinoma tumor. Therefore, Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN is an effective gene therapy, and Fe(3)O(4)-dextran-anti-βHCG nanoparticles are a harmless and effective gene vector. Dove Medical Press 2013 2013-11-06 /pmc/articles/PMC3826771/ /pubmed/24235832 http://dx.doi.org/10.2147/IJN.S44739 Text en © 2013 Huining et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed. |
spellingShingle | Original Research Huining, Liu Yi, Zhang Dihong, Tang Yifeng, Pan Man, Xia Ting, Yang Jingting, Cai Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase |
title | Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase |
title_full | Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase |
title_fullStr | Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase |
title_full_unstemmed | Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase |
title_short | Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase |
title_sort | inhibition of choriocarcinoma by fe(3)o(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826771/ https://www.ncbi.nlm.nih.gov/pubmed/24235832 http://dx.doi.org/10.2147/IJN.S44739 |
work_keys_str_mv | AT huiningliu inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase AT yizhang inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase AT dihongtang inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase AT yifengpan inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase AT manxia inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase AT tingyang inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase AT jingtingcai inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase |